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Abstract
Hypertension is one of the most common disease but it has adverse effects on target
organs such as heart, brain, kidneys, and blood vessels if not treated properly. The
management of hypertension could be different in some special population, such as
in the elderly. In this population, there are special things to be considered, such as
antihypertension drugs choices and blood pressure target. The purpose of this article
was to provide information about the current management of hypertension in the
elderly. The method used was systematic review with PRISMA protocol. Journal review
results concluded that antihypertensive drugs therapy in elderly starts at blood pressure
> 140/90 mmHg (130/85 mmHg if there is complication of diabetes, kidney disease,
and cardiovascular); optimum target of systolic blood pressure is 120-140 mmHg and
diastolic blood pressure not less than 65 mmHg; antihypertension drugs choices base
on comorbidities and patient response to medication; and lifestyle modification is
necessary to reduce cardiovascular risk and reduce the amount of drug consumed.
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1. Introduction
Epidemiological transition leads to change disease patterns from communicable dis-
eases to non-communicable diseases [1]. The occurrence of this epidemiological tran-
sition is due to changes in socioeconomic, environmental, and population structure.
People have adopted an unhealthy lifestyle, such as smoking, lack of physical activity,
and high-fat/alcohol consumption. The unhealthy lifestyle is thought to be a risk factor
for non-communicable diseases. The World Health Organization estimates that by 2020
non-infectious diseases will account for 73% of deaths and 60% of all morbidity in the
world. It is estimated that themost affected countries are developing countries, including
Indonesia [2].
Hypertension is one of the non-communicable diseases that are common in everyday
clinical practice. Data of Riset Kesehatan Dasar 2013 shows that the prevalence of
hypertension in Indonesia is 25.8% [3]. Hypertension has effects on many target organs
such as the heart, brain, kidney, and blood vessels [4].
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Early detection, such as regular blood pressure measurement and appropriate man-
agement, can reduce complication risk. Hypertension can attack all ages, but older
people are more common to have the disease. Hypertension in the elderly requires
special treatment because there is an interaction between hypertension and cardiovas-
cular risk factors [5, 6]. This is confirmed by results of Hypertension in the Very Elderly
Trial (HYVET) and The Systolic Blood Pressure Intervention Trial (SPRINT) study which
state that management of hypertension in elderly patients needs to be distinguished
from adult patients to reduce morbidity and mortality [7–9]. This paper compares some
articles from international journals which explain about the treatment of hypertension in
elderly.
Hypertension in elderly needs to be discussed because it often finds cases of mild
hypertension in elderly that does not get any treatment. Besides, the blood pressure
target that has to be achieved sometimes confuses the clinicians. Hopefully, this paper
can provide detail information about the management of hypertension in the elderly.
This article was created to discuss some articles of international journals on the treat-
ment of hypertension in the elderly. The authors feel the need to discuss this because
during this understanding of the community often find it commonwhen found high blood
pressure in the elderly, so no treatment is done. Target blood pressure to be achieved
even sometimes confuse the clinicians. It is hoped that this paper can provide new and
detailed information about the management of hypertension in the elderly, both medical
and non-medical procedures.
2. Methods
This paper used systematic review based on the Preferred Reporting Items for System-
atic Review and Meta Analyzes Statement (PRISMA) 2009 (10).
2.1. Search strategy (Literature search and literature selection)
Literatures are searched by using electronic databases such as Springer Link, Proquest,
and Google Scholar with the keyword ”hypertension in elderly patients” and using pub-
lished journals from 2010 to 2016. Inclusion criteria are all articles from various countries
about hypertension in elderly, in English, has a citation, and published in 2010-2016
while the exclusion criteria are articles that are not relevant to the topic of hypertension
in the elderly.From 3 electronic databases f,from 2010 to 2016, researchers obtained 991
journal articles consisting of 40 articles from Springer Link, 141 articles from ProQuest,
and 810 articles from Google Scholar. Firstly, the articles were filtered by keyword, then
title, inclusion and exclusion criteria and finally researchers assess the full article. There
were seven articles relevant to the topic consisting of research articles, meta-analysis
and systematic review (Figure 1).
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Title selection (n =19) 
Article (n= 7) 
Not relevant (n = 12) 
Not relevant (n= 972) 
Searching in database by keyword (n =991) 
· Proquest ( n = 141) 
· Spinger Link (n = 40) 
· Google scholar (n = 810) 
Figure 1: The process/diagram for searching the articles.
3. Results
Table 1: Summary of the article included in the systematic review.















Antihypertension therapy starts at blood pressure >
140/90 mmHg (130/85 mmHg when there are
complications of diabetes, kidney disease and
cardiovascular).
- Lifestyle modification needs to be done such as
increasing physical activity, low-sodium diet, reducing
weight / maintaining ideal body weight and reducing
alcohol consumption.
- The degree of decreased blood pressure is more
important than the selection of antihypertension drugs.
- Combination therapy is the renin-angiotensin system
blocker with diuretics or with calcium channel blockers.
- The management of hypertension in elderly is
influenced by many factors such as the tendency for
orthostatic hypotension, polypharmacy, and incidence
of cognitive impairment.
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Selection of anti-hypertension drugs is not based on
the age of patients because the drugs have the same
effect between elderly patients and adult patients.
- Antihypertension drugs begin to be given when
systolic blood pressure (SBP) > 140 mmHg, the target
of SBP is < 140 mmHg.
- Be aware of drug side effects.
- There is an advantage when giving anti-hypertension
drugs to healthy elderly people aged > 80 years, but
be careful of existing comorbidities, such as dementia.
- Drug combination such as Angiotensin Converting
Enzyme (ACE) inhibitor with diuretic or calcium
antagonist. Beta-receptor blockers are given when












If SBP <150 mmHg has been achieved with 1 or 2
antihypertension drugs, then it can be considered to
lower SBP <140 mmHg. If the patient ages ≥ 80 years,
SBP 140-145 mmHg is acceptable. SBP ≥ 150 mmHg is
still acceptable if a combination of 4 types of target
antihypertensive drugs is still unreachable; there are
unwanted side effects, and diastolic blood pressure
(DBP) drops to ≤ 65 mmHg.
- Lifestyle modification.
- Recommended antihypertension drugs are ACE
inhibitor group, angiotensin receptor blocker (ARB),
calcium channel blocker, a beta-blocker, or diuretic.
Beta-blockers can not be used as first-line therapy
when there is no indication.
- Be aware of the risk of orthostatic hypotension















Lifestyle modification can be done in patients with mild
hypertension, such as stop smoking, lose weight,
reduce stress, salt, and alcohol, as well as increase
physical activity. It can lower the doses of drugs taken.
- Selection of anti-hypertension drugs depends on the
patient’s condition. Use of diuretics is not
recommended for patients with electrolyte disorders,
calcium antagonists may be administered to patients
with arterial dysfunction, but should be avoided by
patients with left ventricular dysfunction. For patients
with diabetes can be given ACE inhibitors.
- Compared with diuretics, ACE inhibitors have a better
effect on cardiovascular and reduce the risk of kidney
disease.
- Intake of water needs to be considered because






















Combination of indapamide SR 1.5mg ± perindopril 2-4
mg decreased SBP by 17 mmHg and DBP 7 mmHg
compared with placebo in systolic and diastolic
hypertensive patients. In ISH patients, the effects of
both drugs decreased SBP 19.3 mmHg and DBP 2
mmHg.
- The risk of stroke is reduced by 30% by reducing SBP.
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Lowering blood pressure up to 150/90 is still
acceptable.
- Lifestyle modifications such as healthy diet, weight
control, and regular physical exercise, are
recommended because it can lower blood pressure
























In patients over the age of 75, reducing a patient’s
blood pressure to 120 mmHg compared to 140 mmHg
has a significant effect on fatal cardiovascular events
and other causes of death.
4. Discussion
Management of hypertension in the elderly is same as amanagement in an adult patient,
which is preceded by a non-medical therapy that is lifestyle modification, combined with
themanagement of antihypertension drug therapy [7, 8, 11, 12]. Hypertensive patients are
encouraged to reduce salt/sodium and alcohol consumption [7, 12]. Smoking as a risk
factor for cardiovascular disease also needs to be stopped. Patients also need to reduce
stress because it can also trigger a rise in blood pressure [12]. Other examples of lifestyle
modification are weight loss and regular physical activity [7, 8, 12]. Non-medical therapy
can reduce the consumption of anti-hypertension drugs [8]. Anti-hypertension drugs
are given according to each patient’s condition and are not age-based [6, 12]. Treat-
ments that can be given are drugs from the class of ACE inhibitors, angiotensin receptor
blockers (ARBs), calcium channel blockers, beta-blockers, and diuretics [11]. The use of
diuretics is not recommended for patients with electrolyte disorders, calcium antagonists
may be administered to patients with arterial dysfunction, but should be avoided by
patients with left ventricular dysfunction. For patients with diabetes can be given ACE
inhibitors [11]. Compared with diuretics, ACE inhibitors have a better cardiovascular effect
and reduce the risk of kidney disease [12]. From the results of HYVET research, the
combination of an anti-hypertension drug indapamide SR 1.5 mg ± perindopril 2-4 mg
reduced SBP by 17 mmHg and DBP 7 mmHg compared with placebo in systolic and
diastolic hypertensive patients. In ISH patients, the effects of both drugs decreased SBP
19.3 mmHg and DBP 2 mmHg [13].
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From the journals above, there are differences regarding blood pressure that begins
to be treated with medication and blood pressure target to be achieved. There are
statements to start anti-hypertension drug therapy at blood pressure > 140/90 mmHg or
130/85 mmHg when there are complications of diabetes, kidney disease, and cardiovas-
cular [7]. Meanwhile, the others only pay attention to SBP> 140 mmHg [6]. Systolic blood
pressure reduction target also varies, which is < 140 mmHg and up to 120 mmHg [6, 14].
Systolic blood pressure ≥ 150 mmHg is still acceptable in conditions in which patients
already get a combination of 4 types of anti-hypertension drugs; there are unwanted
drug side effects, and DBP decreases to≤65mmHg [11]. Things to consider when admin-
istering anti-hypertension drugs are side effects such as orthostatic hypotension [7,
11]. Polypharmacy also often occurs because elderly patients usually consume drugs
for other diseases therapy [7]. Water intake should be monitored to avoid electrolyte
disturbance [12].
5. Conclusion
Treatment of anti-hypertension drugs in elderly starts at blood pressure > 140/90 mmHg
(130/85mmHg if there is a complication of diabetes, kidney disease, and cardiovascular).
The optimum target of systolic blood pressure is 120 - 140 mmHg and diastolic blood
pressure is not less than 65 mmHg. Anti-hypertension drugs are adjusted to comorbidi-
ties and patient response. Lifestyle modification is needed to reduce cardiovascular risk
and reduce the amount of drug consumed.
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